whether patients should get genetic tests to help determine dosing for warfarin or clopidogrel (Plavix)

May 2010

There's new debate about whether patients should get genetic tests to help determine dosing for warfarin or clopidogrel (Plavix)....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Women's Health new OTC oral fluconazole (CanesOral, etc) for vaginal yeast infections
Psychiatry doubt about whether gabapentin (Neurontin, etc) works for neuropathic pain and other off-label uses
Ophthalmology new ophthalmic quinolone called Besivance
Travel Medicine New Canadian guidelines will help pregnant women who travel
whether patients should get genetic tests to help determine dosing for warfarin or clopidogrel (Plavix)
Dermatology concerns about using Protopic (tacrolimus) and Elidel (pimecrolimus) for eczema in kids
There's still debate about when and how to taper oral steroids
Pediatrics melatonin for insomnia in CHILDREN
Infectious Diseases New guidelines on treating Clostridium difficile infections
Interactions QT prolongation drug interaction alerts
Neurology & Pain Jurnista, a new once-daily oral hydromorphone